Analystreport

TCR2 Therapeutics Inc. (NASDAQ: TCRR) had its price target lowered by analysts at Piper Sandler from $23.00 to $15.00.

TCR2 Therapeutics Inc.  (TCRR) 
Last tcr2 therapeutics inc. earnings: 11/12 07:00 am Check Earnings Report